Efficacy News and Research

RSS
New dye offers breakthrough in deep tissue imaging and cancer therapy

New dye offers breakthrough in deep tissue imaging and cancer therapy

New procedure standard/practice guideline released for fibroblast activation protein PET

New procedure standard/practice guideline released for fibroblast activation protein PET

New approach uses peptides to enhance anti-tumor drug formulations

New approach uses peptides to enhance anti-tumor drug formulations

Researchers identify key factors for successful donor lymphocyte infusion in AML patients

Researchers identify key factors for successful donor lymphocyte infusion in AML patients

Online app supports weight loss through protein and fiber tracking

Online app supports weight loss through protein and fiber tracking

Advances and challenges in brain implant technology

Advances and challenges in brain implant technology

Breakthrough gene discovery offers new hope for medulloblastoma therapy

Breakthrough gene discovery offers new hope for medulloblastoma therapy

AI-based blood test could revolutionize diagnosis of Long Covid in children

AI-based blood test could revolutionize diagnosis of Long Covid in children

NUS researchers develop DNA barcoded nanoparticles for targeted cancer therapy

NUS researchers develop DNA barcoded nanoparticles for targeted cancer therapy

Research could lead to better medicines and new tools in synthetic biology

Research could lead to better medicines and new tools in synthetic biology

Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity

Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity

Study reveals sex-specific differences in microglial response to CSF1R inhibition

Study reveals sex-specific differences in microglial response to CSF1R inhibition

New compound V-161 offers hope in the fight against antibiotic-resistant bacteria

New compound V-161 offers hope in the fight against antibiotic-resistant bacteria

Multi-omics approach identifies potential drug combinations for AML treatment

Multi-omics approach identifies potential drug combinations for AML treatment

New approach to treating ependymoma with leukemia drug

New approach to treating ependymoma with leukemia drug

Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patients

Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patients

Metronomic chemotherapy offers hope for children with neuroblastoma

Metronomic chemotherapy offers hope for children with neuroblastoma

Prehabilitation associated with fewer complications and improved recovery after surgery

Prehabilitation associated with fewer complications and improved recovery after surgery

Prehabilitation may improve surgical recovery and reduce complications

Prehabilitation may improve surgical recovery and reduce complications

Real-world effectiveness and safety of olaparib in HRD-positive BRCA wild-type ovarian cancer

Real-world effectiveness and safety of olaparib in HRD-positive BRCA wild-type ovarian cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.